MRP-L39 Antibodies

Santa Cruz Biotechnology offers a broad range of MRP-L39 monoclonal antibodies for research applications. MRP-L39 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MRP-L39, also known as mitochondrial ribosomal protein L39, plays a crucial role in mitochondrial protein synthesis and is essential for the proper functioning of the mitochondrial ribosome. MRP-L39 is involved in the translation of mitochondrial mRNA, which is vital for the production of proteins necessary for cellular respiration and energy production. Understanding MRP-L39 function advances knowledge of mitochondrial diseases and their impact on cellular metabolism. Research utilizing MRP-L39 monoclonal antibodies has revealed significant insights into mitochondrial biology and disease mechanisms. Investigating MRP-L39 expression patterns helps identify potential therapeutic targets for mitochondrial disorders. Current studies with MRP-L39 monoclonal antibodies continue to uncover new aspects of mitochondrial function and regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of mitochondrial biology and its role in human health.